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Chapter I
 
Literature Review
 
BACKGROUND INFORMATION OF VACCINIA VIRUS
 
Vaccinia virus (VV) is the prototype member of the
 
viral genus Orthopoxviridae, whose members infect a wide
 
variety of vertebrate hosts.  VV is a large enveloped
 
double-stranded DNA virus with a characteristic brick
 
shaped morphology.  The VV genome of approximately 200 kbp
 
encodes more than 250 gene products.  Replication takes
 
place entirely within the cytoplasm of an infected cell,
 
largely independent of nuclear involvement (Moss, 1990a).
 
VV does not display a restricted host range characteristic
 
of many eukaryotic DNA viruses.  The above features;
 
cytoplasmic site of replication, large genomic coding
 
capacity, and wide host range make VV particularly amenable
 
as a research tool.  VV has been utilized in many different
 
fields of biology, including; vaccine development,
 
developmental biology, DNA replication, protein
 
transcription and translation, and virus-host interactions.
 
VACCINIA VIRUS REPLICATION
 
The process of virus replication can be divided into
 2 
several steps: attachment and penetration, uncoating,
 
replication, assembly, maturation, and release. (Figure
 
1.1)  Attachment of the virion to the host cell in many
 
viruses is mediated by means of specific receptor-ligand
 
interactions, however, no cellular receptor has been
 
identified for utilization of VV to gain entry into cells.
 
Next penetration and uncoating occur.  Although very little
 
is known about this process, it is believed that
 
penetration occurs via a specific receptor initiating
 
endocytosis of the virus.  Through this process, the virus
 
can begin uncoating due to changes in both environmental pH
 
as well as three-dimensional structure of the virion
 
itself.  Proteins required for early gene transcription
 
have been packaged into the infecting virion such as DNA-

dependent RNA polymerase, early transcription factors
 
(which recognize early promoter sequences), DNA
 
topoisomerase type 1, and other enzymes involved in mRNA
 
synthesis (Moss, 1990a).  The following step, early gene
 
translation, provides VV proteins necessary for
 
intermediate gene expression and DNA replication.
 
Concurrent with, or directly preceding dissolution of the
 
structural core components, DNA replication begins.  The
 
newly replicated VV genome is found as a catenated molecule
 
within the virus factories in the cytoplasm.  Newly
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Figure 1.1
 
Vaccinia virus replication cycle. Numbers
 
represent the major stages of the virus life cycle.
 
1) Uncoating  I.  2) Early gene expression. 3) Uncoating II.
 
4) DNA Replication. 5)  Intermediate gene expression.
 
6) Late gene expression. 7) Virion assembly.
 
8) Proteolytic maturation. 9) Release.
 
(Hansen and Hruby,  In press)
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replicated DNA is employed as the template for intermediate
 
gene expression, and it encodes a set of late transcription
 
factors (Keck et. al., 1990).  The late genes encode the
 
structural proteins, as well as virion enzymes and early
 
gene transcription factors, which are to be packaged into
 
the assembling virion.  The cascade of protein expression
 
(early, intermediate, and late) during replication of VV is
 
tightly regulated in a temporal fashion.  Assembly of the
 
new virions begins as genomes and structural elements
 
become available.  Virions first become infectious
 
following assembly, and proteolysis of the precursor
 
proteins within the assembled virion.
 
PROTEOLYSIS "LIMITED"
 
During a productive VV infection, viral proteins
 
undergo a number of post-translational modifications; these
 
include acylation, phosphorylation, glycosylation, ADP­
ribosylation, and proteolytic processing (VanSlyke and
 
Hruby, 1990).  Enzymes that are provided by the host cell,
 
the virus, or both can perform these protein modifications.
 
Proteolytic processing in general is particularly
 
interesting, for while the specificity of any one reaction
 
differs, it is a mechanism of protein modification that is
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conserved in many prokaryotic and eukaryotic systems.
 
Proteolysis is defined as the cleavage of peptide
 
substrates by an enzyme capable of hydrolyzing the
 
susceptible scissile bond.  The processing of proteins via
 
proteolysis is ubiquitous among different biological
 
systems, and is essential for sustaining most biosynthetic
 
pathways.  In addition, the breakdown process of proteins
 
is unidirectional.  There are no known proteins capable of
 
re-ligating the products of a proteolytic reaction,
 
presumably because the free energy required to do so is too
 
high.  "Limited proteolysis" first described by
 
Linderstrom-Lang and Ottesen (1949) refers to the selective
 
hydrolysis of peptide bonds within a polypeptide, as
 
opposed to non-specific degradation of proteins.
 
Modifications introduced by limited proteolysis can be used
 
to regulate protein activation, expression, or, as in the
 
case of VV, maturation of the virus.
 
CLASSIFICATION OF PROTEASES
 
Proteases are divided into two groups, peptidases and
 
proteinases, based on the particular type of cleavage event
 
(Polgar, 1989).  Peptidases, also exopeptidases, are
 
responsible for the cleavage of single or dipeptide units
 
from either the amino or carboxy terminus of a protein.
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Proteinases, or endopeptidases are proteases that recognize
 
a specific amino acid sequence or motif within a peptide
 
chain.  Proteinases can be further classified into one of
 
four groups according to the amino acids participating in
 
catalysis, and their mechanism of action.  Serine
 
proteinases contain a catalytic triad of aspartic acid,
 
histidine, and serine.  Cysteine proteinases possess a
 
catalytic dyad of cysteine and histidine.  The third type
 
of proteinase, the aspartic proteinases have two aspartic
 
acid residues participating in catalysis.
 
Metalloproteinases, the last class, require the addition of
 
water and a divalent cation into the active site for
 
catalysis.  Metalloproteinases contain a structural
 
catalytic triad that contains glutamic acid with two
 
histidine residues.  The divalent cation, usually Zn2+, is
 
further stabilized by a downstream glutamic acid distinct
 
from the catalytic pocket (Barrett, 1995).
 
REQUIREMENTS OF PROTEASES
 
For catalysis of a specific peptide bond to take
 
place, two structural requirements must be met.  First, the
 
region of catalysis must be defined by the amino acids
 
neighboring the susceptible bond.  This is required for
 
determining both the primary and secondary specificity of
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the proteinase for its substrate.  Polgar in 1987,
 
discussed primary and secondary specificity as containing
 
both qualitative and quantitative features.  Primary
 
specificity is qualitative in its selection of the scissile
 
bond, and the secondary specificity imparts a quantitative
 
feature by facilitating the cleavage of the selected bond.
 
Some proteinases are promiscuous in either of these
 
features.  For example, a well-known proteinase, trypsin
 
cleaves only after basic amino acid residues regardless of
 
the neighboring amino acids.  In contrast, recognition of a
 
peptide backbone instead of specific amino acids is
 
characteristic of pancreatic elastase.  The second
 
requirement for proteolysis is that the susceptible peptide
 
bond should be accessible to the proteinase in a flexible
 
region.  The selected bond should also fit in a three-

dimensional conformation into the active site of the
 
proteinase.  This second requirement is regarded as
 
conformational specificity of the enzyme for its substrate
 
(Wright, 1997).  Proteinases contain a catalytic site and a
 
substrate-binding site.  Often these two sites are in close
 
proximity of one another in the folded protein.  The active
 
site of the proteinase can be formed either contained
 
within one polypeptide, or when two protein monomers come
 
together to form the catalytic pocket.
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FORMATIVE AND MORPHOGENIC
 
In viral systems, there are two types of limited
 
proteolytic mechanisms, either formative or morphogenic
 
(Hellen and Wimmer, 1992b).  Formative proteolysis is the
 
processing of structural and non-structural proteins from a
 
larger precursor polyprotein.  Retroviruses and the
 
positive-strand RNA viruses have taken advantage of
 
formative proteolysis as a means of expressing several
 
proteins from a single RNA template.  Once cleavage occurs,
 
structural proteins can be targeted to their proper
 
location and non-structural proteins can be activated.
 
There are numerous references in the literature of enzymes
 
that perform formative cleavage, but perhaps the best known
 
is the Human Immunodeficiency Virus (HIV) aspartic acid
 
proteinase.  In the case of this enzyme, the catalytic dyad
 
is formed with the dimerization of two monomers.  (Loeb
 
1989, Blundell 1990)
 
In contrast to formative proteolysis, morphogenic
 
cleavage refers to the processing of assembled viral
 
structural proteins during morphogenesis or maturation of
 
the virus.  Associated with the maturation process,
 
morphogenic proteolysis is thought to be required for the
 
acquisition of infectivity of both RNA and DNA viruses,
 
such as VV, HIV, picornaviruses, and bacteriophage T4
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(Kraeusslich and Wimmer, 1988; Hellen and Wimmer, 1992b).
 
In the case of HIV, the cleavage of the polyprotein
 
precurser is essential for proper genomic RNA dimerization
 
into immature virions. (Stewart 1990)  Activation of HIV
 
proteinase prematurely, was shown by Kraeusslich (1991) to
 
abrogate maturation and subsequently the infectivity of the
 
virus.  Bacteriophage T4 structural proteins must be
 
processed for DNA to be properly packaged. (Hershko and Fry
 
1975)  The proteinase from bacteriophage T4 is activated
 
after autoproteolytic cleavage, commonly utilized as a
 
mechanism for regulating proteinases. (Showe 1976)
 
In general, it is essential that proteinases be accurately
 
regulated to prevent aberrant proteolysis before assembly.
 
This is achieved in a number of ways including
 
compartmentalization of enzymes from their substrates,
 
proteolytic activation of zymogens, the presence of
 
inhibitors or co-factors, and the requirement for
 
contextual presentation of a given substrate (Webster
 
1993) .
 
PROTEOLYTIC PROCESSING IN VACCINIA VIRUS
 
The first indication that VV proteins were processed
 
via proteolysis came in 1967 when Holowczak and Joklik
 
observed differences in the molecular weights of
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radiolableled proteins present in VV-infected cells 
compared to those found in purified virions.  Pulse chase
 
experiments following the above observation, identified the
 
relationship between many protein products and their
 
precursors.  A few secreted, non-structural proteins, such
 
as hemagglutinin have been shown to be cleaved during the
 
course of a VV infection (Stroobant 1985, Shida 1986,
 
Kotwal and Moss 1988).  More importantly, at least six
 
virion-associated proteins are derived from precursor
 
proteins, namely 4a, 4b, 25K, 23K, 21K, and 17K (VanSlyke
 
1991, Whitehead and Hruby 1994).  Alignment of the amino
 
acid sequences of the precursor proteins at the determined
 
cleavage sites revealed a conserved Ala-Gly-X motif (AG*X).
 
This predicted cleavage motif is conserved in variola major
 
virus, the causative agent of the human disease smallpox
 
(Schelkunov 1993).  There is also conservation of the
 
cleavage site of the precursors p25K and p4b when compared
 
to their fowlpox homologues FP5 and F4b respectively (Binns
 
et. al. 1988, 1989).  Of the processed proteins, 4a, 4b,
 
and 25K are the three most abundant proteins in the VV
 
particle (Moss and Rosenblum 1973, Silver and Dales 1982,
 
Yang and Bauer 1988).  Based on such strict conservation of
 
the AG*X motif, and the processing of the major virion
 
proteins, the importance of this type of modification in
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the VV replication cycle readily becomes apparent.  The
 
AG*X motif is represented 82 times in the entire VV genome,
 
however only nine of these sites, present in five proteins,
 
have been established as targets of proteolysis.
 
Therefore, factors other than the required AG*X motif are
 
also responsible for the specificity of processing.  All
 
five substrates are expressed at late times during VV
 
replication, and are present for a considerable time before
 
being processed.  Proteins containing the AG*X motif that
 
are expressed at early times of infection have not been
 
demonstrated to undergo proteolysis.  This suggests not
 
only the necessity for the AG*X motif, but indicates that
 
processing of these proteins is constrained temporally as
 
well.  The above also suggests that the responsible
 
proteinase is of viral origin, as cellular protein
 
synthesis is shut off early during a viral infection.
 
Infected cells were blocked for late viral gene expression
 
in order to determine the gene that was responsible for the
 
proteolytic activity.  The cells were then transfected with
 
a plasmid copy of a VV-protein substrate, and transcription
 
factors required for late gene expression.  Co-transfection
 
of cosmid clones representing the entire VV genome were
 
used in order to determine the region necessary to rescue
 
proteolytic processing.  The only open reading frame
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sufficient to rescue processing was the G11, open reading
 
frame (ORF). (Whitehead and Hruby, 1994).
 
GIL
 
The entire sequence of the VV genome has been
 
published and based on this, the product of the G11, ORF is
 
predicted to be 591 amino acids, and have a molecular
 
weight of approximately 68kDa.  GIL is expected to be
 
soluble and have a pI of 6.29, as would be expected for a
 
cytoplasmic enzyme.  Computer analysis of the amino acid
 
sequence of G11, generated only one motif that resembled any
 
known proteinase, namely the HEXXH pentapeptide of
 
metallopeptidases, albeit in the reverse orientation.  The
 
HXXEH motif is followed by a downstream ENE motif, which is
 
required for stabilization of a divalent cation, presumably
 
zinc, to the protein.  This ENE triplet in G11, provides
 
both the forward and reverse orientations of the NE doublet
 
characteristic of the Pitrilysin family of
 
metallopeptidases.  Mutagenesis studies of the glutamate
 
residue within HXXEH motif, in the transprocessing assay
 
described earlier, did in fact abolish the processing.  In
 
addition, mutagenesis of the glutamate residue within the
 
ENE tripeptide abrogated processing (Whitehead and Hruby,
 
1994).  The above data strongly suggest the hypothesis that
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the G11, ORF encodes the proteinase responsible for
 
processing and maturation of VV.
 
METALLOPEPTIDASES CLASSIFICATION
 
Metalloproteinases are the most diverse group of
 
catalytic peptidases, comprising 30 families.  These
 
enzymes contain the HEXXH motif that has been shown by X-

ray crystallography to form part of the binding site for
 
divalent cations, most often Zn2++.  The two histidine
 
residues within the motif bind the zinc atom and the
 
glutamic acid (Glu) has a catalytic function.  The Glu
 
residue promotes the nucleophilic attack of a water
 
molecule on the carbonyl carbon atom of the peptide bond,
 
forming a tetrahedral intermediate (Weaver et. al., 1977).
 
Metalloproteinases are divided into five "clans" based on
 
the catalytic site containing two zinc ligands as well as a
 
third stabilizing zinc ligand located away from the
 
catalytic pocket.  In the first clan, named MA, a glutamic
 
acid residue downstream of the HEXXH motif completes the
 
metal-binding site.  Clan MA is the most thoroughly
 
characterized containing, thermolysin and other enzymes
 
from both prokaryotic and eukaryotic organisms.  Clan MB
 
has another histidine residue as the third ligand.  A
 
completely conserved methionine residue in all members of
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this clan indicates that it serves a vital function in the
 
structure of the active sites of the enzymes.  This has led
 
to the use of the term "metzincins" for the peptidases of
 
this clan, and the most well known are the human
 
interstitial collagenase, and fibrolase.  The three
 
remaining clans have not been named, but the third is
 
comprised of members whose motif is HEXXH, but their third
 
metal ligands are not known.  An interesting member of this
 
clan is immune inhibitor A, an endopeptidase from Bacillus
 
thuringiensis, a bacterium that is a pathogen of
 
lepidoptera and is used as a bio-agent in the control of
 
these lepidopteran pests in agriculture (Loevgren, et. al.
 
1990).  The fourth clan contains metalloproteinases for
 
which it is known that the essential metal atoms are bound
 
at motifs other than HEXXH.  There are five families in
 
this clan with representatives from a diverse array of
 
organisms, such as pitrilysin from E. coli, and human
 
insulin degrading enzyme (IDE) from humans.  The fifth and
 
final group contains those families for whom the metal
 
ligands are not known.  Members of this clan include
 
membrane dipeptidase, and glutamate carboxypeptidase.
 
The motif found in the G1L ORF shows similarity with the
 
fourth clan of metalloproteinases, and more specifically to
 
the family Pitrilysin. (Figure 1.2)  The Pitrilysin family
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Figure 1.2. The amino acid alignment of the catalytic
 
residues of some of the members of the Pitrilysin Family of
 
metalloendopeptidases.  The high degree of conservation
 
between divergent organisms within the catalytic pocket is
 
clearly evident, and would suggest the importance of this
 
motif to function of the protein.
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CATALYTIC SEQUENCE 
GLS HFCEH MLF
 
GLS HFCEH MLF
 
GLA HFCEH MLF
 
GLA HYLEH MSL
 
GIS HFLEH MFF
 
GLA HLLEH LLF
 
GIA HLLEH LLI
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contains two subfamilies of enzymes: Pitrilysin and the
 
Mitochondrial Processing Peptidase subfamilies.
 
Characteristic of these sub-families, is an inverted zinc-

binding domain, HXXEH, and a downstream Glu that acts as
 
the third zinc ligand.  Site-directed mutagenesis studies
 
have identified the two His residues found at positions 88
 
and 92 in mature pitrilysin to bind zinc, and Glu-91 to be
 
the catalytic residue.  The third zinc ligand in pitrilysin
 
is glutamic acid at position 169.  Similarly, the family of
 
IDEs showed a loss in proteolytic activity when either the
 
histidines or the glutamic acid were mutagenized, but
 
interestingly IDE retained its insulin binding
 
characteristics, indicating that the substrate, as
 
expected, binds at a site distal to the catalytic pocket.
 
The IDEs represent a newly identified superfamily of
 
metallopeptidases typified by an inverted HEXXH motif.
 
Although fundamental questions concerning the biological
 
role of IDEs remain, the high degree of conservation among
 
members of this clan would suggest that it has an important
 
biological significance.  Considering Gil, may in fact be a
 
member in the same family of metalloendopeptidases, and the
 
first metalloproteinase to be described in a viral system,
 
the overall significance of studies concerning this enzyme
 
are evident.
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INHIBITORS OF METALLOENZYMES
 
Proteinases must be efficiently regulated to ensure
 
that no damage occurs to proteins other than the intended
 
target.  Organisms have developed a number of interesting
 
mechanisms to by-pass this inherent feature of peptidases.
 
Expression of a protein that inhibits a particular
 
proteinase is a common theme, and protein inhibitors are
 
present in multiple forms in numerous tissues (Kato and
 
Laskowski, 1980).  Often these protein inhibitors are
 
specific for a particular proteinase, just as the
 
proteinase is specific for a particular target.  Chemical
 
inhibitors on the other hand can be rather promiscuous in
 
their inhibitory effect.  For instance, EDTA, a chelator of
 
divalent cations, shows only specificity for some but not
 
all peptidases requiring a metal atom for catalysis.
 
Phosphoramidon, another chemical inhibitor, inhibits all
 
metalloenzymes from Clan MA but not those from Clan MB,
 
making it somewhat more specific than EDTA.  Finally, there
 
are more specific chemical inhibitors, these are often
 
times derived synthetically in the laboratory, and inhibit
 
only one proteinase.  Synthetic chemical inhibitors show
 
promise in medicine for the treatment of many congenital
 
diseases, including rheumatoid arthritis.  IDE can be
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inhibited by a number of chemicals including; 1,10­
phenanthroline, 1,7-phenanthroline, bacitracin, and N­
ethlymaleimide.  In addition to these, IDEs have also been
 
shown to be inhibited by excess amounts of insulin, as well
 
as excess amounts of zinc.  The inhibition of insulin
 
degrading activity with these inhibitors was shown with the
 
purified form of IDE.  1,10-phenanthroline is a chelator of
 
divalent cations, and 1,7-phenanthroline its non-chelating
 
isomer, which with purified IDE shows only a minor
 
inhibitory effect.  The antibiotic bacitracin is a chemical
 
inhibitor that is known to form a complex with zinc, and
 
has been shown to inhibit pitrilysin, a member of the same
 
family as IDE.  N-ethylmaleimide (NEM) has been used in
 
cancer research and is thought to have an anti-mitotic
 
effect.  NEM has also been used as an inhibitor of IDEs,
 
and shows greater inhibitory effect than 1,10
 
phenanthroline (Chang and Bai, 1996).
 
It was of interest to determine if these chemical
 
inhibitors could inhibit VV at the level of proteolytic
 
maturation.  It would be expected that if G1L were the
 
proteinase responsible for the maturation process, and if
 
it were a metalloproteinase as indicated by previous
 
experiments, then the process of maturation would be
 
suspended when an infection was subjected to treatment with
 20 
an inhibitor.  This thesis outlines the experiments carried
 
out to investigate the effect these chemical inhibitors
 
have on VV replication, and at what step in the process of
 
VV replication inhibition is observed.
 21 
Chapter II
 
INTRODUCTION
 
Vaccinia virus (VV), a member of Orthopoxviridae is a
 
large enveloped DNA virus that replicates entirely within
 
the cytoplasm of an infected host cell.  The 200 kbp genome
 
of VV encodes for over 250 gene products.  During a
 
productive VV infection, a number of proteins undergo post-

translational modifications, which include acylation,
 
phosphorylation, glycosylation, ADP-ribosylation, and
 
proteolytic processing (VanSlyke and Hruby, 1990).
 
Modification of proteins is believed to be essential for
 
correct sub-cellular localization of both structural and
 
non-structural VV proteins.  In addition, maturation and
 
acquisition of infectivity is thought to be dependent on
 
proteolysis of structural proteins.  A number of VV
 
proteins are processed from higher molecular weight
 
species, and these are 4a, 4b, 25K, 23K, 21K, and 17K.
 
Cleavage of each of these proteins has been shown to occur
 
at a common motif, namely, at an AG*X site, where (*)
 
indicates the site of cleavage.  Based on conservation of
 
this motif within VV as well as between virus species, it
 
is possible that a single enzyme is responsible for
 
processing.  The processed proteins are expressed only at
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late times during infection, and proteins containing the
 
AG*X motif expressed earlier in replication are not
 
cleaved.  This indicates that the specificity of the
 
protease is regulated not only at a structural level, but
 
also temporally with respect to replication.  Rescue of
 
proteolytic processing during a trans-processing assay was
 
achieved with the G11, ORF.  Sequence comparison of the G11,
 
ORF with all other known proteolytic enzymes revealed
 
homology of the catalytic motif of a family of enzymes
 
known as the insulin degrading enzymes (IDE).  As the name
 
might imply, this family of proteases is responsible for
 
the clearance of the circulating hormone, insulin.  The
 
catalytic motif, HXXEH, is a direct inversion of the motif
 
found in most known metalloproteinases.  In addition, found
 
within the G11, ORF is a downstream ENE triplet, this
 
provides both the forward and reverse orientation of the
 
obligate NE dipeptide found in the family of IDEs.  The
 
glutamate of the dipeptide is required for stabilization of
 
the zinc atom during catalysis.  Mutagenesis of the
 
proposed catalytic motif, in the transprocessing assay
 
abrogated processing, indicating further the possibility
 
that G11, is the responsible proteinase, as mutagenesis
 
studies with IDE showed similar results.  The strict
 
conservation of the HXXEH motif as well as the downstream
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ENE tripeptide led to the working hypothesis that G1L is a
 
metalloproteinase involved in the proteolytic maturation of
 
VV during a productive infection.
 
Proteinases are ubiquitous in nature and so are the
 
protein inhibitors associated with them.  It is imperative
 
that a biological system designed to degrade proteins is
 
properly regulated, and one way of achieving this goal is
 
proper expression of inhibitors.  With the exception of
 
macroglobulins, which "inhibit" proteinases of all classes,
 
individual protein inhibitors inhibit only proteinases
 
belonging to a single mechanistic class (Kato and
 
Laskowski, 1980).  As proteinases show specificity, so do
 
their inhibitor counterparts.  Chemical inhibitors as
 
opposed to protein inhibitors also show in many cases a
 
high degree of specificity, although often times they can
 
inhibit an entire class of proteinases.  An example of this
 
would be phosphoramidon, which inhibits Clan MA of
 
metalloendopeptidases but not those of Clan MB.
 
Based on the homology between IDE and G1L it was of
 
interest to determine if G1L could be inhibited by the same
 
chemicals that have been shown to inhibit the IDEs.  Some
 
inhibitors of the IDEs are, I,10-phenanthroline which is a
 
divalent cation chelator, and N-ethylmaleimde.  1,7­
phenanthroline is the non-chelating isomer of 1,10­24 
phenantholine.  In the absence of the ability to purify the
 
protein product of the G11, ORF, our attention turned to the
 
possibility that inhibitors of the IDEs when added to a VV
 
infection would inhibit replication at the step of
 
proteolytic morphogenesis.  I report here the results of
 
testing the ability of various metalloproteinase inhibitors
 
to inhibit VV replication.
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Chapter III
 
MATERIALS AND METHODS
 
Cells and viruses
 
African green monkey kidney BSC-40 cells, a derivative
 
of BSC-1 cells selected for their ability to grow at 40°C,
 
were grown in monolayers.  These cells were maintained in
 
Eagle minimum essential medium (MEM)  (Sigma), and were
 
supplemented with 10% heat inactivated fetal calf-serum, 2
 
mM L-glutamine, and lOug /ml of gentamycin sulfate.
 
Vaccinia virus (strain WR) Western Reserve was obtained
 
from the American Type Culture Collection, and was
 
propagated by low-multiplicity passages and periodic plaque
 
purification.  Infection, purification and titration of
 
cells with VV-WR was carried out as previously described
 
(Hruby 1979a).
 
Serial passages
 
Confluent monolayers of BSC-40 cells (100mm-dishes)
 
were treated with either 1,10-phenanthroline, 1,7­
phenanthroline, N-ethylmaleamide (NEM), insulin, or British
 
Biotech inhibitor, at concentrations of 10mM, 1mM, or
 
0.1mM.  The cells were infected with VV-WR at a
 
multiplicity of infection (moi) of one.  These were
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incubated at 37°C under 5% CO2 95% 02 for 48 hours.  The
 
infected cells were harvested into 5 ml of sterile
 
phosphate buffered saline, and progeny virions were
 
liberated from the cells by three consecutive cycles of
 
freeze thawing.  Titers were determined using a portion of
 
this crude stock, and the remainder was used to infect a
 
new monolayer of BSC-40 cells.  The above steps were
 
repeated a total of six times.
 
One-step growth curve
 
Confluent monolayers of BSC-40 cells (100mm dishes)
 
were infected at a moi of one and treated with either 0.1mM
 
1,10-phenanthroline, 1,7-phenanthroline, or no treatment.
 
Infected cells were harvested at 0,  2,  4,  8,  12, 24, and 48
 
hours post infection, into lml phosphate buffered saline.
 
Virus could be titered after three freeze thaw cycles,
 
which liberates the virus from the cells.  Titration was
 
performed in 6-well dishes of confluent monolayers of BSC­
40 cells as previously described.
 
Metabolic Labeling
 
Confluent monolayers of BSC-40 cells were infected
 
with VV at a moi of five with or without drug, in MEM media
 
deficient for methionine.  Radiolabeled 35S-methionine was
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added to the cultures at the indicated times post
 
infection, incubated 15 minutes, rinsed, and then
 
harvested.  Cells were centrifuged and resuspended in SDS
 
sample buffer for assay by polyacrylamide gel analysis.
 
Following separation of the radiolabeled proteins, the gels
 
were dried and laid against film, and later developed.
 
Electron Microscopy
 
A six well plate containing confluent monolayers of
 
BSC-40 cells were subjected to infection with VV WR at an
 
moi of ten, two wells were subjected to 1,10-phenanthroline
 
treatment 0.1mM, two were treated with 1,7-phenanthroline
 
0.1mM, and two were the control with no treatment.  At 0
 
and 8 hours post infection, the cells were harvested and
 
fixed for transmission electron microscopy, which was
 
carried out by the Electron Microscopy lab at Oregon State
 
University.
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Chapter IV
 
RESULTS
 
Inhibitors
 
The ability of inhibitors to inhibit VV replication.
 
1,10-phenanthroline is a chelator of divalent cations, and
 
N-ethylmaleimide (NEM) inhibits metallopepetidases of the
 
insulin degrading enzyme (IDE) class.  These chemicals have
 
both been shown in studies to inhibit the action of
 
purified IDE from degrading cellular insulin.  The studies
 
described above were carried out with a purified form of
 
IDE.  G1L, the predicted target of inhibition by 1,10­
phenanthroline and NEM, has not been purified.  Based on
 
the sequence homology between the class of IDEs and G1L,
 
however, G1L might be susceptible to inhibition by both
 
1,10-phenanthroline, NEM.  Included in the inhibition
 
studies were the non-chelating isomer of 1,10­
phenanthroline, 1,7-phenanthroline, as well as an inhibitor
 
obtained from British Biotech, NEM, and insulin (Table
 
IV.1).  The inhibitor from British Biotech is a matrix­
metalloproteinase inhibitor, and was chosen in order to
 
exclude the possibility that G1L encodes a proteinase from
 
Clan MA of metalloendopeptidases.  Insulin was also chosen
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Table IV.1 shows the ability of a given chemical to inhibit
 
replication of VV in BSC-40 cells.  Included in this table
 
is the susceptibility of the cells themselves to possible
 
toxic effects of each inhibitor.
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Table IV.1 
Chemical Inhibitor  Inhibitor Concentration  Virus Titer  Cellular Toxicity 
1,10-Phenanthroline 
1 mM 
0.5 mM 
0.1 mM 
0 
0 
4 X 10 
+ 
+ 
+/­
1,7-Phenanthroline 
1 mM 
0.5 mM 
0.1 mM 
0 
8 x 10 
2 x 10 
+ 
-
-
N-Ethylmaleimide 
1 mM 
0.5 mM 
0.1 mM 
0 
0 
0 
+ 
+ 
+ 
Bacitracin 
1 mM 
0.5 mM 
0.1 mM 
0 
0 
0 
+ 
+ 
+ 
BB-British Biotech 
1 mM 
0.5 mM 
0.1 mM 
0 
0 
0 
+ 
+ 
+ 
Insulin  100 mM  6 x 10 31 
as studies have shown that increasing concentrations of
 
insulin are inhibitory to the IDEs.
 
One step growth curve analysis
 
Figure IV.1 is a graphic representation of a one-step
 
grown curve of either wild-type WR strain alone, or in the
 
presence of either 1,10-phenanthroline or 1,7­
phennathroline.  As indicated the titer of WR alone at 48
 
hours was approximately  1 X 109 pfu, and the 1,7­
phenanthroline was also on the order of 1 X 109 pfu.  The
 
infection with 1,10-phenanthroline, however, did not
 
increase and the final titer was three logs below that of
 
either the WR or 1,7-phenanthroline.  Of interest also is
 
the 1,7-phenanthroline curve that shows about a 2-hour lag
 
compared to the WR only.
 
Serial passage in the presence of inhibitors
 
The acquisition of drug resistant VV mutants in the
 
past has been accomplished often, by serial passage of the
 
virus in the presence of a given chemical.  Following the
 
addition of a chemical to an infection of VV, there is a
 
notable drop in viral titer, due to virus that is incapable
 
of replicating in the presence of the drug.  After a number
 
of passages those virus resistant to the drug are capable
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Figure IV.1.  Graphic representation of a one-step growth
 
analysis of VV in the presence or absence of drug.
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Figure IV.1
 
One Step Growth Curve of VV (+/- Inhibitor) 
Hours Post Infection 34 
of replicating in the presence of the drugs and an increase
 
in titer is seen.  Serial passage of VV in the presence of
 
1,10-phenanthroline, did not produce any drug resistant
 
mutants, indicating that the target of the inhibitor was
 
likely of cellular origin. (Table IV.2)
 
35 S-methionine labeling 
Pulse labeling during a viral infection can be used to
 
gather information about what proteins are being made or
 
processed at specific times.  It was of interest following
 
the one step growth curve to analyze the protein profile of
 
those proteins expressed in the presence or absence of
 
drugs.  Figure IV.2 shows the results of a pulse labeling
 
experiment at different times post infection in the
 
presence or absence of 1,7-phenanthroline, or 1,10­
phenanthroline.  At zero hours post infection all lanes
 
appear to be the same, but at five hours it is clear that
 
the drug treatment has had an effect on viral replication.
 
It appears as though the virus treated with both drugs is
 
incapable of transition from early gene translation to
 
intermediate translation.  However, by eight hours post
 
infection the lane with 1,7-phenanthroline treatment looks
 
similar to WR with no drug at five hours.  This is in
 
accordance with the one step-growth curve where 1,7­35 
Table IV.2.  Serial passage.
 Table IV.2
 
41
  N
 
Virus Titers of Serial Passages
 
Chemical Inhibitor  First Passage  Third Passage  Fifth Passage
 
1,10-phenanttaoline  4 X 106  7 X 10
4  <100
 
1,7-Pbehanthrollne  8 X 10-
7 4 X 106  1 X 10-
7

Western Reserve  7
 6 X 109  3 X 10  7 X 108
 
No Drug
 
N 4
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Figure IV.2.  Pulse-chase labeling analysis of VV proteins
 
in the presence of drug.
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phenanthroline was "behind" the WR only infection by about
 
two hours.  The infection with 1,10-phenanthroline,
 
however, did not exit early gene translation as would be
 
expected by eight hours post infection.  Longer incubation
 
times did not rescue this deficiency in drug treated
 
infections (data not shown).
 
Electron Microscopy
 
Further investigation to determine if the virus was
 
being inhibited at the step of uncoating was done with
 
electron microscopy.  The infection without drug showed
 
normal replication as indicated by figure IV.4.  Infection
 
of the virus in the presence of 1,7-phenanthroline at eight
 
hours showed a slightly slower progression through
 
replication.  The virus is not quite mature at this time
 
point. (Figure IV.5)  This is in agreement with the one-

step growth curve as well as the pulse labeling
 
experiments.  Figure IV.6 shows a virus infection in the
 
presence of 1,10-phenanthroline was very interesting
 
however.  It appears as though endocytocis is completed,
 
but that the virus remains within the endocytic vesicle, as
 
indicated by the arrow.  There was some cellular toxicity
 
as some cells were amitochondrial when infected in the
 
presence of 1,10-phenanthroline, but cells that were
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not deficient in mitochondria, and showed an arrest of VV
 
replication, were found to have these large endocytic
 
vesicles.
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Figure IV.4.  Electron microscopic analysis of VV
 
replication Western Reserve.  This is an electron
 
micrograph of a VV at eight hours post infection.  Mature
 
virions are clearly evident, and the magnification is
 
28,000x.
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Figure IV.3
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Figure IV.5.  Electron microscopic analysis of VV
 
replication in the presence of 1,7-phenanthroline.  At
 
eight hours post infection the virions have not matured,
 
but have been assembled.  The magnification of this field
 
is 35,000x.
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Figure IV.6.  Electron microscopic analysis of VV
 
replication in the presence of 1,10-phenanthroline.  This
 
micrograph is at a magnification of 10,000x, and as
 
indicated by the arrow, there is an endocytic vessicle with
 
particles contained within it.
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Figure IV.5
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Chapter IV
 
Discussion
 
Very little is known about the process of uncoating of
 
VV during a productive infection.  It is thought that
 
following receptor mediated endocytosis, that there are two
 
successive steps of uncoating.  First, the outer envelope
 
is released, and early gene products are shuttled to the
 
cytoplasm and translated.  Second, the core is broken down
 
and DNA replication begins.  The enzymes and proteins
 
involved in this process of uncoating have not been
 
identified.  Utilizing the chemical inhibitor 1,10­
phenanthroline, I was able to show that a protein that
 
might be involved in uncoating of the virus is likely to be
 
of cellular origin as opposed to viral.  If the protein
 
responsible for uncoating were of viral origin, one might
 
expect to be able to derive a drug resistant mutant, as has
 
been done many times in the past.  One-step growth curve
 
analysis showed that replication was being inhibited very
 
effectively.  Further, pulse labeling of a viral infection
 
in the presence of the drug indicated that transition from
 
early gene translation to intermediate gene translation was
 
suspended.  Finally, electron microscopy indicated that at
 
least part of the time virus was being endocytosed, but
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that it was not able to proceed from the endocytic vesicle
 
to the cell even after eight hours.  It appears that
 
addition of 1,10-phenanthroline at the time of infection
 
inhibits the viral replication cycle at the level of core
 
uncoating.  It is probable that the target of the
 
inhibition is a protein of cellular origin, as no drug
 
resistant mutants were obtained.
 
The next step to determine whether 1,10-phenanthroline
 
would inhibit G1L, the putative metalloproteinase, would be
 
to add 1,10-phenanthroline two to four hours after a
 
productive VV infection has been established.  This would
 
bypass the inhibition at the level of uncoating and perhaps
 
a drug resistant mutant could be acquired.
 
1,7-Phenanthroline showed a sight inhibition and a
 
time lag in the one-step growth curve, the radiolabeling
 
experiment, and in the electron microscopy experiment.  It
 
has been shown previously that 1,7-phenanthroline does
 
exhibit some degree of inhibition against purified human
 
IDE, however, this inhibition is not a chelating action but
 
rather a non-specific, non-competitive type of inhibition.
 
In the above experiment rescue of enzymatic activity of IDE
 
was achieved by addition of Z1-12-' for 1,10-phenanthroline but
 
not by 1,7-phenanthroline.  It is not surprising then that
 
some amount of inhibition was observed in the presence of
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the non-chelating chemical 1,7-phenanthroline.  It is
 
possible that addition of excess Zn2+ following a VV
 
infection in the presence of 1,10-phenanthroline would
 
rescue the inhibition of replication.
 
It is clear that the replication of VV in the presence
 
of 1,10-phenanthroline inhibited the replication cycle,
 
most likely at the level of uncoating.  Perhaps not so
 
clear, is what protein this drug is inhibiting.  If the
 
protein involved is a cellular protein as thought based on
 
these experiments, it would be difficult to ascertain which
 
protein it is.  It is possible that there was no inhibition
 
to a protein but rather a disruption of various ion
 
channels and a breakdown in the integrity of the cellular
 
membranes.  However, work done previously has shown that
 
neither 1,7-, nor 1,10-phenanthroline cause significant
 
abrogation of transport, integrity, or permeability of rat
 
derived epithelial tissue.
 
Overall, the results of these experiments suggest that
 
in the presence of 1,10-phenanthroline, during a productive
 
infection of VV, the replication cycle is impaired at the
 
level of uncoating.  This suggests that one or more
 
cellular metalloproteinases may be involved in liberating
 
the incoming virus from the endocytic vesicle, and in
 50 
disrupting the core to allow intermediate gene expression
 
to occur.
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